Shenzhen Stock Exchange issued a letter of concern to Sinopharm Zhaoxiang, the controlling shareholder of Zixin Pharmaceutical, to clearly explain the reasons for not preparing a report on changes in equity


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login